How does MD's Q1 forecast compare to past trends?

Pediatrix Medical's (MD) estimated EPS and revenue for Q1 2025 are $0.23 and $458.24 million, respectively. When compared to the previous year's Q1 estimates for EPS and revenue, MD's performance shows a decline in EPS and a slight increase in revenue:

|code|Ticker|Name|Date|Estimate EPS|Estimate Revenue|market_code|
|---|---|---|---|---|---|---|
|MD|MD.N|Pediatrix Medical|2023 Q2|0.39|4.9447E8|169|
|MD|MD.N|Pediatrix Medical|2023 Q3|0.43|5.0825E8|169|
|MD|MD.N|Pediatrix Medical|2023 Q4|0.32|5.2334E8|169|
|MD|MD.N|Pediatrix Medical|2024 Q1|0.19|4.9908E8|169|

This indicates a challenging trend for MD, with a decrease in earnings potential and a modest increase in revenue compared to the same period last year. The company's performance should be monitored closely to assess the impact of any underlying factors contributing to these trends.